IBEX Reports Record Quarterly Revenue and EPS, Returns to Double-Digit Growth, Raises Fiscal Year Guidance

Core Insights - IBEX Limited reported strong financial results for the third fiscal quarter ended March 31, 2025, achieving an 11% revenue growth, the highest in ten quarters, driven by performance in key verticals such as HealthTech, Travel, Transportation and Logistics, and Retail & E-commerce [4][5][10]. Financial Performance - Revenue for the quarter was $140.7 million, up from $126.8 million in the prior year, marking an 11.0% increase [2][5]. - Net income slightly increased to $10.5 million from $10.3 million year-over-year, with a net income margin of 7.4%, down from 8.1% [2][6][13]. - Adjusted net income was $11.8 million, a decrease of 6.1% from $12.6 million in the prior year quarter [2][13]. - Adjusted EBITDA was $19.4 million, a 0.9% increase from $19.2 million in the prior year quarter, with an adjusted EBITDA margin of 13.8% [2][10][36]. Earnings Per Share - Diluted earnings per share increased to $0.73 from $0.57, representing a 27.5% growth [2][13]. - Adjusted diluted earnings per share rose to $0.82, an increase of 17.9% compared to the prior year quarter [2][13]. Strategic Developments - The company achieved a strategic milestone by launching operations in India with a leading healthcare client, enhancing client delivery options [4][10]. - A new share repurchase plan was authorized, allowing the company to repurchase up to $15 million of its shares over the next 12 months, reflecting management's confidence in the business [4][11][12]. Guidance and Outlook - The company raised its fiscal year 2025 guidance for both revenue and adjusted EBITDA, expecting revenue in the range of $540 to $545 million, up from a previous range of $525 to $535 million [14]. - Adjusted EBITDA is expected to be in the range of $68 to $70 million, with capital expenditures projected to remain between $15 to $20 million [14].